Results 11 to 20 of about 18,378,232 (237)

Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis [PDF]

Frontiers in Medicine, 2022
Introduction: Despite intensive research, reliable blood-derived parameters to detect clinically significant portal hypertension (CSPH) in patients with cirrhosis are lacking.
Lukas Sturm, Lukas Sturm, Dominik Bettinger, Lisa Roth, Katharina Zoldan, Laura Stolz, Chiara Gahm, Jan Patrick Huber, Marlene Reincke, Rafael Kaeser, Rafael Kaeser, Tobias Boettler, Wolfgang Kreisel, Robert Thimme, Michael Schultheiss   +14 more
doaj   +3 more sources

THE ROLE OF ELASTOGRAPHY IN CLINICALLY SIGNIFICANT PORTAL HYPERTENSION [PDF]

Arquivos de Gastroenterologia, 2023
This is a narrative review that aims to discuss the importance of elastographic methods in the evaluation of clinically significant portal hypertension (CSPH) in cirrhotic patients, where the authors propose an algorithm for evaluating these patients. In
Angelo Alves de MATTOS, Angelo Zambam de MATTOS, Giovana Dal Pozzo SARTORI, Gustavo Tovo BOTH, Cristiane Valle TOVO   +4 more
doaj   +3 more sources

Endoscopic ultrasound‐guided portal pressure gradient identifies patients with previously undiagnosed clinically significant portal hypertension

Portal Hypertension & Cirrhosis
Aims Portal hypertension (PH) is a complication of cirrhosis that leads to hepatic decompensation. Assessing the portal pressure gradient (PPG) provides valuable information for disease assessment, staging, and prognosis.
Jerome C. Edelson, Scott F. D. Edelson, John G. Quiles, Cyrus V. Edelson, Eric M. Montminy, Christian L. Horn, John P. Magulick, Don C. Rockey   +7 more
doaj   +2 more sources

Clinically significant portal hypertension in patients with primary biliary cholangitis: Clinicopathological features and prognostic value

Annals of Hepatology
Introduction and Objectives: Primary biliary cholangitis (PBC) may progress to clinically significant portal hypertension (CSPH) before the development of cirrhosis.
Ying Zhang, Huaying Lai, Jing Chen, Ruimin Lai, Xiaoyu Lin, Shan Lin, Bingping Liu, Qiuxiang Lin, Bin Wang, Qi Zheng   +9 more
doaj   +2 more sources

Laparoscopic hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: a systematic review and meta-analysis [PDF]

World Journal of Surgical Oncology
Objective To compare the effects of laparoscopic hepatectomy (LH) on the short-term and long-term outcomes in hepatocellular carcinoma (HCC) patients with and without clinically significant portal hypertension (CSPH).
Zhi-qiang Xiang, Ya-chen Wu, Xi-lin Qu, Dan-jie Luo, Hao Liang, Sajid Ameer, Zhang-tao Long, Xiao-ming Dai, Zhu Zhu   +8 more
doaj   +2 more sources

Portal Hypertension—Noninvasive Multiparametric Ultrasound‐Based Criteria and Measurements

Portal Hypertension & Cirrhosis
Portal hypertension, the most common complication in liver cirrhosis, is characterized by a pathologic increase in portal venous pressure. Portal hypertension is defined as a pressure gradient greater than 5 mmHg between the portal vein and the inferior ...
Kathleen Möller, Riyad Abu El Hija, Xiaolong Qi, Christian Jenssen, Sven Mutze, Burkhard Möller, Benjamin Misselwitz, Christoph F. Dietrich   +7 more
doaj   +2 more sources

Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease. [PDF]

, 2021
Patients with compensated advanced chronic liver disease have different prognoses depending on the presence of portal hypertension. Current non-invasive diagnostic methods allow identification of clinically significant portal hypertension.
Berzigotti, Annalisa, Rodrigues, Susana G., Vuille-Lessard, Élise   +2 more
core   +3 more sources

MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension. [PDF]

Eur Radiol, 2022
OBJECTIVES Portal hypertension (PH) is associated with complications such as ascites and esophageal varices and is typically diagnosed through invasive hepatic venous pressure gradient (HVPG) measurement, which is not widely available.
Kennedy P, Stocker D, Carbonell G, Said D, Bane O, Hectors S, Abboud G, Cuevas J, Bolster BD, Friedman SL, Lewis S, Schiano T, Bhattacharya D, Fischman A, Thung S, Taouli B.   +15 more
europepmc   +2 more sources

Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis. [PDF]

, 2023
BACKGROUND The diagnosis of clinically significant portal hypertension is crucial for prognosis and treatment guidance in patients with compensated advanced chronic liver disease (ACLD).
Elkrief, Laure, Grgurevic, Ivica, Stefanescu, Horia, Chang, Pik Eu Jason, Colecchia, Antonio, Reiberger, Thomas, Hirooka, Masashi, Piscaglia, Fabio, Rautou, Pierre-Emmanuel, Ravaioli, Federico, Fraquelli, Mirella, Mueller, Sebastian, Berzigotti, Annalisa, Rosselli, Matteo, Zykus, Romanas, Marasco, Giovanni, Llop, Elba, Dajti, Elton, Colli, Agostino, Festi, Davide   +19 more
core   +2 more sources

Methods for assessing portal hypertension

Медицина неотложных состояний, 2023
Many researchers and clinicians have taken the value of hepatic venous pressure gradient (HVPG) as an essential prognostic factor in subjects with chronic liver diseases. HVPG ≥ 10 mmHg indicates the presence of clinically significant portal hypertension,
S.M. Chooklin, S.S. Chuklin
doaj   +1 more source